Cannabis Investment Firm Acquires Publicly Traded COBI to Create Marijuana Penny Stock Company BANGI
Cannabis Investment Firm Acquires Publicly Traded COBI to Create Marijuana Penny Stock Company BANGI |
[19-November-2018] |
CHICAGO, Nov. 19, 2018 /PRNewswire/ -- Bangi Investments, LLC has acquired publicly traded company Compass Biotechnologies, Inc. (Stock Symbol OTC: COBI) to gain greater access to public markets and to continue expanding its success in the cannabis marketspace. The company will go by the name BANGI, (pronounced bon-ghee), which is a noun in the African dialect Swahili meaning "marijuana" or "hemp". "Real Estate is agnostic to the cannabis industry; every sector from cultivation to extracting and retail relies heavily upon it. I'm excited about the prospects in store for BANGI, and I will be instrumental in this transition over the next 90 days," said Rick Shykora, CEO of Compass Biotechnologies, Inc. BANGI, a diversified investment vehicle that acquires and leases specialized real estate assets, understands the integral role that real estate plays in the $30 billion cannabis industry and plans to further its reach with the acquisition of COBI. BANGI will trade as OTC: COBI until approval for its unique ticker symbol. To learn more visit www.bangistock.com. BANGI INVESTMENTS, LLC COMPASS BIOTECHNOLOGIES, INC. BANGI INVESTMENTS, LLC FORWARD-LOOKING STATEMENTS View original content:http://www.prnewswire.com/news-releases/cannabis-investment-firm-acquires-publicly-traded-cobi-to-create-marijuana-penny-stock-company-bangi-300752662.html SOURCE Bangi Investments, LLC | ||
Company Codes: OTC-PINK:COBI, OtherOTC:COBI |
© 2018 PR Newswire. All Rights Reserved.